• S&P 500: 1,342.64
  • Change: -0.69%
$3.49 -0.18 (-4.90%)
2/10/2012 3:59 PM

Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Current Price $3.49 Mkt Cap $66.42M
Open $3.67 P/E Ratio 0.00
Prev. Close $3.67 Div. (Yield) N/A (N/A)
Daily Range $3.45 - $3.67 Volume 160,457
52-Wk Range $1.92 - $6.72 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think AGEN will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

146 Outperform
84 Underperform
 

All-Star Players

36 Outperform
49 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top AGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.27)
Submitted May 06, 2011

0.9 has been a relatively stable floor for Agenus over the last eight months. Potential positive catalysts include presentation of data from phase II trial of Prophage G-200 in glioma and results of several phase III vaccine trials by collaborators… More

Add Comment | Reply | Report this Post

Ernbo6 (62.17)
Submitted May 15, 2007

Antigenics Inc. is a biotechnology company developing technologies and products to treat cancers, infectious diseases and autoimmune disorders, primarily based on immunological approaches. Its advanced product candidate is Oncophage (vitespen,… More

1 Comment | Reply | Report this Post
AGEN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about AGEN.

Recs

0
Member Avatar SarahGen (99.82) Submitted: 8/17/2011 12:13:24 PM : Outperform Start Price: $3.42 AGEN Score: -10.40

they just raised money at 51cents, so that should be a floor for a little while.

Report this Post Add Comment | Reply | Permalink

Recs

1
Member Avatar zzlangerhans (99.27) Submitted: 5/6/2011 2:13:16 AM : Outperform Start Price: $5.34 AGEN Score: -34.76

0.9 has been a relatively stable floor for Agenus over the last eight months. Potential positive catalysts include presentation of data from phase II trial of Prophage G-200 in glioma and results of several phase III vaccine trials by collaborators using the QS-21 adjuvant. The absence of revenues resulting from Russian approval of Oncophage seems to be a forgotten issue.

I still believe that Agenus's immunotherapy pipeline isn't much more than a scam. On the other hand, their vaccine adjuvant seems to have attracted some fairly deep-pocketed collaborators. At this price and in a simulated situation, Agenus gets the benefit of the doubt for now.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar ExploitTopFools (99.15) Submitted: 8/1/2010 10:08:46 PM : Outperform Start Price: $5.40 AGEN Score: -55.35

next round of speculative outperformers. very risky (except for the few at the end of the list).

tickers: gkk,anpi,tstr,agen,htm,ddss,vtg,erii,swhc,brnc,chk,bgp,bks,hlcs,cog,jec,gy

Report this Post Add Comment | Reply | Permalink
View All 32 Pitches »

Leaderboard

Find the members with the highest scoring picks in AGEN.

Score Leader

stockgripes

stockgripes (98.27) Score: +154.36

The Score Leader is the player with the highest score across all their picks in AGEN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
TWreckz 99.42 6/5/2009 Underperform 5Y $15.90 -78.05% +42.14% +120.19 0 Comment
1or5stars 96.48 6/8/2009 Underperform 3W $13.68 -74.49% +44.67% +119.16 0 Comment
svande8952 < 20 6/16/2009 Underperform 5Y $12.24 -71.49% +46.49% +117.98 1 Comment
TMFBiologyFool 97.67 6/12/2009 Underperform 5Y $12.18 -71.35% +43.86% +115.21 2 Comments
rcbaldwinjr 51.61 8/5/2009 Underperform 3W $13.85 -74.81% +35.36% +110.17 0 Comment
rhinomaj 91.65 8/4/2009 Underperform 3M $14.34 -75.66% +34.51% +110.17 0 Comment
epc53 94.52 8/7/2009 Underperform 5Y $13.26 -73.68% +33.74% +107.42 0 Comment
Lifeguru 62.32 4/10/2007 Underperform 5Y $23.16 -84.93% -1.85% +83.08 0 Comment
ortiz176 60.08 4/14/2008 Underperform 1Y $15.48 -77.45% +5.10% +82.55 0 Comment
stockerace 96.95 4/18/2007 Underperform 3W $23.88 -85.39% -3.10% +82.28 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackWMBlair 89.96 1/5/2012 Outperform NS $2.12 +64.62% +5.04% +59.59 0 Comment
trackglobalhunte 55.98 12/1/2011 Outperform NS $2.44 +43.03% +7.62% +35.41 0 Comment
trackmlvcapital 78.21 9/13/2011 Outperform NS $3.42 +2.05% +14.79% -12.74 0 Comment
TrackDawsonJames 65.30 6/1/2011 Outperform NS $5.58 -37.46% -0.11% -37.34 0 Comment
TrackRodmanRen < 20 5/9/2011 Outperform NS $5.75 -39.33% -0.42% -38.91 0 Comment

Featured Broker Partners